Table 2 Case reports of pheochromocytoma-induced cardiogenic shock requiring mechanical circulatory support
From: Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock
First author | Year | Patients with cardiac assist device, n | Mean age (years) | Sex | Initial LVEF (%) | Mechanical circulatory support; duration (days) | ICU-admission -to-surgery interval (days) | Hospital survival |
|---|---|---|---|---|---|---|---|---|
Takagi [17] | 2000 | 1 | 52 | M | 9 | ECMO and IABP; 3 | NR, after ECMO weaning | Yes |
Grinda [18] | 2006 | 1 | 49 | M | 12 | ECMO, then LVAD; 4, then 70, respectively | 4 | Yes |
Ouchikhe [19] | 2006 | 1 | 23 | M | 20 | ECMO, then Thoratec BiVAD; 84 | 93 | Yes |
Kim [20] | 2007 | 1 | 47 | M | 23 | ECMO and IABP; 10 | 15 | Yes |
Chao [21] | 2008 | 1 | 42 | M | 20 | ECMO and IABP; 7 | 18 | Yes |
Zegdi [22] | 2008 | 1 | 51 | F | 30 | ECMO; 6 | 30 | Yes |
Huang [23] | 2008 | 3 | 25 | F | NR | ECMO and IABP; 4 | NR, after ECMO weaning | Yes |
42 | M | NR | ECMO and IABP; 7 | NR, after ECMO weaning | Yes | |||
41 | F | <NR | ECMO and IABP; 2 | NR, after ECMO weaning | Yes | |||
Grasselli [24] | 2008 | 1 | 47 | F | 30 | ECMO; 4 | 7 | Yes |
Suh [25] | 2008 | 1 | 43 | M | 27 | ECMO and IABP; 4 | 56 | Yes |
Wu [26] | 2008 | 2 | 42 | M | 34 | ECMO and IABP; 8 | 21 | Yes |
40 | M | 30 | ECMO and IABP; 4 | 12 | Yes | |||
Newton [27] | 2008 | 1 | 45 | M | 10 | CBP to facilitate pheochromocytoma surgery; 1 | 1 | Yes |
Park [28] | 2009 | 1 | 41 | M | 20 | ECMO and IABP; 2 | 30 | Yes |
Westaby [12] | 2009 | 1 | 27 | M | 15 | CBP and adrenalectomy, then LVAD; 6 | 1 | Yes |
Raikhelkar [29] | 2010 | 1 | 38 | M | 5 | Thoratec BiVAD; 4 | 24 | Yes |
Xeridat [25] | 2011 | 1 | 16 | F | 20 | ECMO; 6 | 21 | Yes |
Ritter [30] | 2011 | 1 | 49 | F | 10 | ECMO; 8 | 8 | Yes |
Nakajima [31] | 2011 | 1 | 33 | F | 19 | ECMO and IABP; 4 | 120 | Yes |
Contargyris [32] | 2012 | 1 | 20 | M | 20 | ECMO; 2 | 30 | Yes |
Sojod [33] | 2012 | 1 | 37 | F | 15 | ECMO; 11 | 21 | Yes |
Sheinberg [34] | 2012 | 1 | 45 | F | 5 | ECMO and IABP; 3 | 56 | No |
Noorani [35] | 2012 | 1 | 39 | F | NR | Central ECMO; 5 | 3 | Yes |
Banfi [36] | 2012 | 1 | 20 | F | 20 | Central ECMO; 6 | 120 | Yes |
Kaese [37] | 2013 | 1 | 43 | M | NR | ECMO; 9 | NR, after ECMO weaning | Yes |
Law [38] | 2013 | 1 | 23 | F | 5 | ECMO; 1 | NR, after ECMO weaning | Yes |
Shawa [39] | 2014 | 1 | 38 | F | 15 | Tandem Heart; 1 | 26 | Yes |
Riester [1] | 2015 | 2 | 18 | F | NR | Impella; 2 | No surgery | No |
25 | F | NR | ECMO; NR | NR, after ECMO weaning | Yes | |||
Chao [2] | 2015 | 4, 2 with IABPa | 25 | F | NR | ECMOa | NR, after ECMO weaning | Yes |
52 | M | NR | ECMOa | NR, after ECMO weaning | Yes | |||
40 | M | NR | ECMOa | NR, after ECMO weaning | Yes | |||
65 | M | NR | ECMOa | Refused surgery | Yes | |||
Zhou [40] | 2015 | 1 | 35 | M | 20 | ECMO and IABP during cardiac paraganglioma resection; 16 | Cardiac paraganglioma resection, date unknown | Yes |
Flam [10] | 2015 | 1 | 46 | F | 15 | ECMO; 5 | 66 | Yes |
Vagner [41] | 2015 | 1 | 55 | F | 15 | Impella, then ECLS; 2 | 56 | Yes |
Spangenberg [14] | 2015 | 1 | 29 | F | 10 | ECMO and IABP; 1 | No surgery | No |
Kodama [9] | 2016 | 1 | 37 | F | 10 | ECMO; NR | NR, before ECMO weaning | Yes |
Dang Van [42] | 2016 | 1 | 57 | M | 10 | ECMO, 7 | NR, concomitant from the ECMO implantation | Yes |